Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2026-05-04 @ 2:03 AM
Study NCT ID:
NCT05993702
Status:
UNKNOWN
Last Update Posted:
2023-08-15
First Post:
2023-08-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TAS-102 in Combination With Regorafenib or Fruquintinib for Third-line and Above Advanced Colorectal Cancer
Sponsor:
China Medical University, China
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PRAY
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None